Trending
According to Dior Couture, this taboo fashion accessory is back
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uber and Lyft are finally available in all of New York State
The final 6 ‘Game of Thrones’ episodes might feel like a full season
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
Nonprofit buys experimental cancer drug to maintain patient access
Potential Cocaine Addiction Targets Identified Through Genetic Mapping in Rats
New mRNA Delivery Platform Restores Muscle Function in DMD Models
STAT+: Abridge inks deals with Nvidia and Lilly
Summit pulls $500M share sale a day after announcing it
Fighting Antimicrobial Resistance with Biomaterials and Phages
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
STAT+: Novartis doubles down on molecular glue strategy
Genentech executes another round of layoffs, with 3 VPs axed
DaltonTx launches AI drug discovery platform
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Who are the early favorites to win the NFL rushing title?
The old and New Edition cast comes together to perform
Boxing continues to knock itself out with bewildering, incorrect decisions
Steph Curry finally got the contract he deserves from the Warriors
Phillies’ Aaron Altherr makes mind-boggling barehanded play
The tremendous importance of owning a perfect piece of clothing
9 Celebrities who have spoken out about being photoshopped
6 Stunning new co-working spaces around the globe
3 Ways to make your business presentation more relatable
5 Crowdfunded products that actually delivered on the hype
Startup adds beds and Wi-Fi to buses to turn them into ‘moving hotels’
Model Jocelyn Chew’s Instagram is the best vacation you’ve ever had
Your comprehensive guide to this fall’s biggest trends
10 Artists who retired from music and made a comeback
The 9 worst mistakes you can ever make at work
15 Habits that could be hurting your business relationships
A photo diary of the nightlife scene from LA To Ibiza
Rappers are blowing up Twitter with praise for Jay Z and ‘4:44’
-
Uncategorized3 hours agoAn obesity drug deep-dive, and peptides move mainstream
Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food...
-
Uncategorized4 hours agoRFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
WASHINGTON — Health secretary Robert F. Kennedy Jr. on Wednesday pointed to his “publicly available calendar” as an example of his commitment to transparency and to...
-
Uncategorized5 hours agoNonprofit buys experimental cancer drug to maintain patient access
In a rare move, nonprofit organization Blood Cancer United announced Thursday it was buying the remaining supplies of Luvelta, a discontinued investigational cancer drug. As part...
-
Uncategorized5 hours ago
Potential Cocaine Addiction Targets Identified Through Genetic Mapping in Rats
Scientists at the University of California San Diego have reported the results of a genome-wide association study in rats that identified key biological drivers of cocaine...
-
Uncategorized6 hours ago
New mRNA Delivery Platform Restores Muscle Function in DMD Models
Although gene therapy has shown promise for the treatment of Duchenne muscular dystrophy (DMD), the limitations of viral vectors have proven challenging to clinical advancement. Now,...
-
Uncategorized7 hours agoSTAT+: Abridge inks deals with Nvidia and Lilly
NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as...
-
Uncategorized8 hours agoSummit pulls $500M share sale a day after announcing it
The developer of a leading PD-1/VEGF cancer drug cited “market conditions” for the cancellation. Its shares have struggled to break out following data milestones.
-
Uncategorized8 hours agoFighting Antimicrobial Resistance with Biomaterials and Phages
Antimicrobial resistance (AMR) is a significant global health threat, with its impact felt across all regions of the world.1 According to the World Health Organization (WHO),...
-
Uncategorized8 hours agoSensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
A strategic review determined that the development environment had "notably changed," leading Sensorion to end work on its gene therapy for OTOF-related hearing loss. Read More
-
Uncategorized9 hours ago
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but...